International Stem Cell (ISCO) Research & Development (2010 - 2026)
International Stem Cell's Research & Development came in at $155,000 for Q2 2026, down 4.3% from $162,000 a year earlier.
Powered by 
Analysis
International Stem Cell (ISCO) Research & Development (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, International Stem Cell reported Research & Development of $652,000, down 12.6% year-over-year; for FY2025, it came in at $684,000, up 4.1% from FY2024.
- Research & Development has increased in each of the last three years, though with a five-year compound annual growth rate of -7.1% (FY2020 to FY2025).
- Going back by year, Research & Development was $657,000 in FY2024 (+28.6%), $511,000 in FY2023 (+3.9%), $492,000 in FY2022 (-29.2%) and $695,000 in FY2021 (-29.7%).
- The Q2 2026 figure represents the lowest quarterly Research & Development since Q2 2024.
- Year-over-year, Research & Development increased in four of the last seven quarters, with growth averaging 16.1%.
- The fastest year-over-year change in Research & Development over five years came in Q2 2025 (growth of 95.2%), and the weakest in Q2 2023 (a decline of 45.8%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,133.02 Bn | 1,101.60 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 616.49 Bn | 535.01 Bn | 17.26 Bn | 3.65 Bn |
| 3 | AbbVie | 501.09 Bn | 474.20 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 366.78 Bn | 321.16 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 297.96 Bn | 261.95 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 261.66 Bn | 235.34 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 235.44 Bn | 190.84 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 190.69 Bn | 164.89 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 169.52 Bn | 116.16 Bn | 10.94 Bn | 2.81 Bn |
| 10 | International Stem Cell | 1.68 Mn | -2.29 Mn | 1.46 Mn | 155,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 155,000.00 |
| Dec 31, 2025 | 177,000.00 |
| Sep 30, 2025 | 158,000.00 |
| Jun 30, 2025 | 162,000.00 |
| Mar 31, 2025 | 187,000.00 |
| Dec 31, 2024 | 210,000.00 |
| Sep 30, 2024 | 187,000.00 |
| Jun 30, 2024 | 83,000.00 |
| Mar 31, 2024 | 177,000.00 |
| Dec 31, 2023 | 166,000.00 |
| Sep 30, 2023 | 155,000.00 |
| Jun 30, 2023 | 45,000.00 |
| Mar 31, 2023 | 145,000.00 |
| Dec 31, 2022 | 125,000.00 |
| Sep 30, 2022 | 147,000.00 |
| Jun 30, 2022 | 83,000.00 |
| Mar 31, 2022 | 137,000.00 |
| Dec 31, 2021 | 203,000.00 |
| Sep 30, 2021 | 165,000.00 |
| Jun 30, 2021 | 113,000.00 |
API Access
International Stem Cell Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=ISCO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "ISCO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=ISCO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();